According to Abiomed's latest financial reports the company's current revenue (TTM ) is S$1.47 Billion. In 2021 the company made a revenue of S$1.35 Billion an increase over the revenue in the year 2020 that were of S$1.07 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | S$1.48 B | 9.47% |
2021 | S$1.35 B | 26.1% |
2020 | S$1.07 B | -5.18% |
2019 | S$1.13 B | 12.68% |
2018 | S$1.00 B | 38.34% |
2017 | S$0.72 B | 21.26% |
2016 | S$0.60 B | 39.93% |
2015 | S$0.42 B | 52.22% |
2014 | S$0.28 B | 25.69% |
2013 | S$0.22 B |